IMDX Insight Molecular Diagnostics, Inc.: Earnings growth forecast for next year
Insight Molecular Diagnostics (IMDX) has implemented data processing automation and targeted robotics on its production lines. The trajectory of forward-looking EPS estimates reflects current dynamics, where 4.60 represents the current level of the metric. Looking ahead, the business relies on stable demand regardless of economic conditions, although it faces fierce competition for the recognition of new diagnostic methodologies within the medical community.
IMDX (Insight Molecular Diagnostics Inc): analytical breakdowns and indicator data
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Insight Molecular Diagnostics|IMDX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Insight Molecular Diagnostics, Inc.|IMDX - Company Total Indebtedness|Debts to Book Capitalization Insight Molecular Diagnostics|IMDX - Company Long-Term Loans and Borrowings|Company Current Liabilities Insight Molecular Diagnostics|Quick Liquidity Indicator imdxinc.com
- net income and valuation ratios data:
IMDX - Final Profit|Expected Profit Insight Molecular Diagnostics|IMDX - Price to Earnings Ratio|Future Price to Earnings Insight Molecular Diagnostics, Inc.|IMDX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Insight Molecular Diagnostics|IMDX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Insight Molecular Diagnostics|IMDX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth imdxinc.com|IMDX - Net earnings per share growth this year|Expected earnings per share growth for next year Insight Molecular Diagnostics
Analysis of all company metrics:Insight Molecular Diagnostics, IMDX
Rising demand for Insight Molecular Diagnostics (IMDX) automated molecular diagnostic systems directly determines the consensus valuation of net profit growth rates. This indicator measures the expected change in earnings per share (EPS) for the coming year, where the current value of 4.60 reflects the aggregate forecast of leading US analysts. Positive momentum on this chart confirms the scalability of the business, although a high degree of conservative valuation may restrain short-term explosive capital growth.
Competitor analysis for Insight Molecular Diagnostics
Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ILMN|Consensus forecast of earnings per share growth for next year exactsciences.com|Net earnings per share growth forecast for next year Revvity RVTY|BIO: Projected earnings per share growth rate for next year|NNNN - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Nordion SHC|QDEL: Earnings growth forecast for next year|OPK - Consensus forecast of earnings per share growth for next year|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|MRVI - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year FLGT|LAB (Standard BioTools Corp) - Expected earnings per share trend next year|Cytek Biosciences, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year OSUR (orasure.com)|XGN: Expected earnings per share growth for next year|Expected earnings per share trend next year MDXH (MDxHealth S.A.)|Lucid Diagnostics Inc (LUCD) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Prenetics|Net earnings per share growth forecast for next year Trinity Biotech PLC|Expected net earnings per share growth next year prophaselabs.com PRPH|Net earnings per share growth forecast for next year Ainos (AIMD)|Net earnings per share growth forecast for next year CODX (Co-Diagnostics Inc)|Earnings growth forecast for next year HSCS (Heart Test Laboratories Inc.)|Biomerica Inc (BMRA) - Expected net earnings per share growth next year|Cardio Diagnostics Holdings, Inc. - Earnings growth forecast for next year|onconetix.gcs-web.com (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs) - Expected earnings per share growth for next year|Bluejay Diagnostics Inc (BJDX) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Vermillion|Net earnings per share growth forecast for next year AXDX|Earnings growth forecast for next year CNTG|Earnings growth forecast for next year enzo.com (ENZ)|Net earnings per share growth forecast for next year Fresh2 Group FRES|Expected earnings per share trend next year GENE|ME: Expected earnings per share growth for next year|Expected earnings per share trend next year PMD (Psychemedics Inc)
